Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: J Drug Issues. 2020 Jul 4;50(4):524–537. doi: 10.1177/0022042620936655

Table 3.

DSM-5 CUD symptoms endorsed by participants (N = 99)

DSM-5 CUD Criteria N (%)
Cannabis is often taken in larger amounts or over a longer period than was intended. 62 (62.6%)
There is a persistent desire or unsuccessful efforts to cut down or control cannabis use. 56 (56.6%)
A great deal of time is spent in activities necessary to obtain cannabis, use cannabis, or recover from its effects. 70 (70.7%)
Craving, or a strong desire or urge to use cannabis. 57 (57.6%)
Recurrent cannabis use resulting in a failure to fulfill major role obligations at work, school, or home. 18 (18.2 %)
Continued cannabis use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of cannabis. 23 (23.2%)
Important social, occupational, or recreational activities are given up or reduced because of cannabis use. 11 (11.1%)
Recurrent cannabis use in situations in which it is physically hazardous. 62 (62.6%)
Cannabis use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by cannabis. 24 (24.2%)
Tolerance 71 (71.7%)
Withdrawal 23 (23.2%)